Although this is similar to our rates for other likely Hb traits (e.g., sickle cell trait and similar secondary findings on NBS), it contrasts with our loss to follow up rate of <1% for likely Hb disease cases (e.g., all genotypes of sickle cell disease). Here, GSTM1 is linked to sickle cell disease.